Background and Aims: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported.

Cantor Fitzgerald issued their FY2025 earnings estimates for Dianthus Therapeutics in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst P. Stavropoulos forecasts that the company ...

We recently published a list of 12 High Growth International Stocks to Invest in Now. In this article, we are going to take a ...

Importantly, PAD is a marker for generalized atherosclerosis and is closely associated with coronary and cerebrovascular disease. The severity of PAD has been correlated with an increased risk of ...

Empasiprubart (ARGX-117) is under development for the delayed graft function and dermatomyositis, multifocal motor neuropathy, chronic inflammatory demyelinating polyneuropathy ... The company’s ...